According to a new report from Intel Market Research, the global Haemorrhagic Stroke Drugs market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.75 billion by 2034, growing at a CAGR of 7.8% during the forecast period (2026-2034). This growth is driven by the rising prevalence of cerebrovascular diseases, aging populations,...
English
Indonesia
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek